These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 25856691)
1. The role of circulating microRNAs as novel biomarkers in diagnosing colorectal cancer: a meta-analysis. Rokkas T; Kothonas F; Rokka A; Koukoulis G; Symvoulakis E Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):819-25. PubMed ID: 25856691 [TBL] [Abstract][Full Text] [Related]
2. Predictive power of circulating miRNAs in detecting colorectal cancer. Zeng W; Tu Y; Zhu Y; Wang Z; Li C; Lao L; Wu G Tumour Biol; 2015 Apr; 36(4):2559-67. PubMed ID: 25527153 [TBL] [Abstract][Full Text] [Related]
3. Circulating microRNAs as a novel class of diagnostic biomarkers in gastrointestinal tumors detection: a meta-analysis based on 42 articles. Wang R; Wen H; Xu Y; Chen Q; Luo Y; Lin Y; Luo Y; Xu A PLoS One; 2014; 9(11):e113401. PubMed ID: 25406082 [TBL] [Abstract][Full Text] [Related]
4. Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients. Du M; Liu S; Gu D; Wang Q; Zhu L; Kang M; Shi D; Chu H; Tong N; Chen J; Adams TS; Zhang Z; Wang M Carcinogenesis; 2014 Dec; 35(12):2723-30. PubMed ID: 25239640 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of circulating miR-21 for colorectal cancer: a meta-analysis. Shan L; Ji Q; Cheng G; Xia J; Liu D; Wu C; Zhu B; Ding Y Cancer Biomark; 2015; 15(1):47-56. PubMed ID: 25524942 [TBL] [Abstract][Full Text] [Related]
6. Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis. Carter JV; Galbraith NJ; Yang D; Burton JF; Walker SP; Galandiuk S Br J Cancer; 2017 Mar; 116(6):762-774. PubMed ID: 28152545 [TBL] [Abstract][Full Text] [Related]
7. The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis. Xu F; Xu L; Wang M; An G; Feng G Colorectal Dis; 2015 May; 17(5):O100-7. PubMed ID: 25683351 [TBL] [Abstract][Full Text] [Related]
8. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Huang Z; Huang D; Ni S; Peng Z; Sheng W; Du X Int J Cancer; 2010 Jul; 127(1):118-26. PubMed ID: 19876917 [TBL] [Abstract][Full Text] [Related]
9. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis. Zhang L; Cao D; Tang L; Sun C; Hu Y Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469 [TBL] [Abstract][Full Text] [Related]
10. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer. Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602 [TBL] [Abstract][Full Text] [Related]
11. The use of circulating microRNAs as diagnostic biomarkers in colorectal cancer. Clancy C; Joyce MR; Kerin MJ Cancer Biomark; 2015; 15(2):103-13. PubMed ID: 25547322 [TBL] [Abstract][Full Text] [Related]
12. A plasma microRNA panel for early detection of colorectal cancer. Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911 [TBL] [Abstract][Full Text] [Related]
13. The clinical use of circulating microRNAs as non-invasive diagnostic biomarkers for lung cancers. Yang Y; Hu Z; Zhou Y; Zhao G; Lei Y; Li G; Chen S; Chen K; Shen Z; Chen X; Dai P; Huang Y Oncotarget; 2017 Oct; 8(52):90197-90214. PubMed ID: 29163821 [TBL] [Abstract][Full Text] [Related]
14. Identification of microRNAs as diagnostic biomarkers in screening of head and neck cancer: a meta-analysis. Zhang M; Zhao LJ; Liang WQ; Mao ZP Genet Mol Res; 2015 Dec; 14(4):16562-76. PubMed ID: 26681002 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection. Chang PY; Chen CC; Chang YS; Tsai WS; You JF; Lin GP; Chen TW; Chen JS; Chan EC Oncotarget; 2016 Mar; 7(9):10663-75. PubMed ID: 26848774 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic value of microRNA-21 in colorectal cancer: an original study and individual participant data meta-analysis. Zhang H; Li P; Ju H; Pesta M; Kulda V; Jin W; Cai M; Liu C; Wu H; Xu J; Ye Y; Zhang G; Xu E; Cai J; Lai M; Xia D; Yang J; Wu Y Cancer Epidemiol Biomarkers Prev; 2014 Dec; 23(12):2783-92. PubMed ID: 25178983 [TBL] [Abstract][Full Text] [Related]
17. The ratio of miR-21/miR-24 as a promising diagnostic and poor prognosis biomarker in colorectal cancer. Hao JP; Ma A Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8649-8656. PubMed ID: 30575905 [TBL] [Abstract][Full Text] [Related]
18. MicroRNAs as noninvasive biomarkers in bladder cancer detection: a diagnostic meta-analysis based on qRT-PCR data. Xiao S; Wang J; Xiao N Int J Biol Markers; 2016 Jul; 31(3):e276-85. PubMed ID: 26954073 [TBL] [Abstract][Full Text] [Related]
19. Blood-Based Circulating MicroRNAs are Potential Diagnostic Biomarkers for Leukemia: Result from a Meta-Analysis. Xu LH; Guo Y; Zhang XL; Chen JJ; Hu SY Cell Physiol Biochem; 2016; 38(3):939-49. PubMed ID: 26938054 [TBL] [Abstract][Full Text] [Related]
20. A Comprehensive Meta-Analysis of MicroRNAs for Predicting Colorectal Cancer. Yan L; Zhao W; Yu H; Wang Y; Liu Y; Xie C Medicine (Baltimore); 2016 Mar; 95(9):e2738. PubMed ID: 26945359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]